海外有望企業情報Peter MacCallum Cancer Centre

Peter MacCallum Cancer Centreはがんに特化した豪州唯一の公立病院であり、国内外で有数の腫瘍拠点として評価されている。国内最多のがん患者を治療し、複数拠点で最大規模の研究体制と包括的診療を統合する。細胞免疫療法や血液がんゲノミクス、分子病理などに強みを持ち、ゲノム検査や初期臨床試験を主導するほか、NexomicsやCell Therapies Pty Ltdを通じて商業研究サービスも展開している。

Peter MacCallum Cancer Centre is Australia’s only public hospital dedicated exclusively to cancer and is widely recognized as a leading oncology center domestically and globally. It treats more cancer patients than any other hospital in the country and integrates comprehensive clinical care with Australia’s largest cancer research program across multiple sites in Victoria. The organization demonstrates strengths in cellular immunotherapy, hematologic cancer genomics, cancer genetics, molecular pathology, and prostate cancer theranostics, while leading national efforts in genomic testing, translational research, and early phase clinical trials through the Parkville Cancer Clinical Trials Unit. It also offers specialized commercial and research services via Nexomics and Cell Therapies Pty Ltd, a leading cell and gene therapy manufacturing organization.